EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort

Guillaume Lefèvre, Séverine Bleuse, Mathieu Puyade, Guillaume Moulis, Antoine Néel, Noémie Abisror, Antoine Baudet, Bernard Bonnotte, Jérémie Dion, Antoine Dossier, Maximilien Grall, François Lifermann und 44 weitere

Allergy · 2025-04 · 80 (4) · 1100-1110

DOI: 10.1111/all.16463 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Allergy, online erschienen am 05.01.2025. Verfasst von Guillaume Lefèvre und 55 weiteren Autor:innen. Beteiligte Einrichtung: Institut d'Immunologie, Service de médecine Interne et d'immunologie Clinique, CHU Lille, INFINITE-Institute for Translational Research in Inflammati…. Hauptthemen laut MEDLINE: Hypereosinophilic Syndrome. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: GSK, AstraZeneca, Lille University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypereosinophilic syndromes (HES) are a heterogenous group of eosinophilic disorders. To date, only retrospective studies of limited sample‐size and/or follow‐up duration are available.

Methods

The COHESion study is a national prospective multicenter multidisciplinary cohort recruiting both adults or children with the spectrum of eosinophilic disorders (including reactive HE/HES [HE/HES‐R], idiopathic HES [HES‐I], lymphocytic HES [HES‐L], neoplastic HE/HES [HE/HES‐N], HE of unknown significance [HE‐US], as well as IgG4‐related disease [IgG4RD] or ANCA‐negative eosinophilic granulomatosis with polyangiitis [EGPA] overlaps). Patients are followed‐up yearly. All data about final diagnosis, organ involvement assessments, and outcome profiles in HES‐I were captured and analyzed centrally by HES expert centers.

Results

From May 2019 to November 2023, 779 patients were included. For this preliminary analysis, 550 cases were available for centralized review (mean ± SD age: 56 ± 18 years, 42% of female patients). The final diagnoses were HES‐I (47%), HE/HES‐R (16%), HE‐US (15%), HE/HES‐N (7%), HE/HES‐L (6%), IgG4RD (2%), and ANCA‐negative EGPA (7%). In the 258 HES‐I patients, outcome profiles were classified as follows: 16.3% had a “single‐flare” without further relapse, 28.3% had a “relapsing–remitting” disease when there was at least a 6‐month period free of symptoms between two flares, 46.1% had a “persistent disease” requiring continuous treatment to avoid relapses (9.3% remained unclassified because of insufficient follow‐up).

Conclusions

The COHESion cohort is the first nationwide prospective multicenter study collecting data on the full spectrum of HE/HES disorders. This preliminary analysis confirms that idiopathic HES patients have various outcome profiles, suggesting different underlying pathophysiological mechanisms and the need of patient‐specific management. Trial Registration ClinicalTrials.gov identifier: NCT 04018118

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypereosinophilic SyndromeAdultAgedChildFemaleHumansMaleMiddle AgedCohort StudiesProspective Studies

Stichwörter der Autor:innen

eosinophileosinophilic granulomatosis with polyangiitishypereosinophiliahypereosinophilic syndrome

Autor:innen und Institutionen

  • Institut d'Immunologie, Service de médecine Interne et d'immunologie Clinique, CHU Lille, INFINITE-Institute for Translational Research in Inflammation, Université de Lille, Lille, France.
  • Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), Suresnes, France.
  • CHU de Poitiers, Service de Médecine Interne et Maladies Infectieuses, Faculté de Médecine et de Pharmacie de Poitiers, Poitiers, France.
  • Département de Médecine Interne, Centre d'Investigation Clinique 1436, équipe PEPSS, CHU de Toulouse, Toulouse, France.
  • Service de Médecine Interne, CHU de Nantes, Nantes, France.
  • AP-HP, Hôpital Saint-Antoine, Service de Médecine Interne and Inflammation-Immunopathology-Biotherapy Department (DMU 3iD), Sorbonne Université, Paris, France.

ORCID-Profile: Vincent Cottin, Frédéric Dezoteux, Camille Taillé

Förderung

  • GSK
  • AstraZeneca
  • Lille University Hospital
  • Foch Hospital
  • Plan National Maladies Rares
  • GlaxoSmithKline España
  • Centre hospitalier régional universitaire de Lille
  • Hôpital Foch

Zitieren

APA

Lefèvre, G., Bleuse, S., Puyade, M., Moulis, G., Néel, A., Abisror, N., Baudet, A., Bonnotte, B., Dion, J., Dossier, A., Grall, M., Lifermann, F., Limal, N., Lioger, B., Machelart, I., Mohr, C., Outh, R., Queyrel-Moranne, V., Slama, B., …, & COHESion study group (2025). Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort. Allergy, 80(4), 1100-1110. https://doi.org/10.1111/all.16463

Vancouver

Lefèvre G, Bleuse S, Puyade M, Moulis G, Néel A, Abisror N, et al. Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort. Allergy. 2025;80(4):1100-1110. doi:10.1111/all.16463

BibTeX
@article{Lefvre2025,
  author = {Lefèvre, Guillaume and Bleuse, Séverine and Puyade, Mathieu and Moulis, Guillaume and Néel, Antoine and Abisror, Noémie and Baudet, Antoine and Bonnotte, Bernard and Dion, Jérémie and Dossier, Antoine and Grall, Maximilien and Lifermann, François and Limal, Nicolas and Lioger, Bertrand and Machelart, Irène and Mohr, Catherine and Outh, Roderau and Queyrel-Moranne, Viviane and Slama, Borhane and Tréfond, Ludovic and Abou Chahla, Wadih and Ackerman, Félix and Belfeki, Nabil and Berezne, Alice and Blade, Jean-Sébastien and Bouderbala, Mohammed Azzedine and Chebrek, Safia and Cottin, Vincent and De Almeida, Sébastien and De Masson, Adèle and Dezoteux, Frédéric and Goulenok, Tiphaine and Jachiet, Vincent and Jouvray, Mathieu and Latu, Irina and Ledoult, Emmanuel and Leurs, Amélie and Lugosi, Maxime and Martin, Michael and Melboucy-Belkhir, Sara and Morati-Hafsaoui, Chafika and Quemeneur, Thomas and Rohmer, Julien and Roy-Peaud, Frédérique and Sanges, Sébastien and Schleinitz, Nicolas and Staumont-Salle, Delphine and Taillé, Camille and Terriou, Louis and Tieulie, Nathalie and Koenga, Japhete Darline Elenga and Schwarb, Laurent and Panel, Kewin and Kahn, Jean-Emmanuel and Groh, Matthieu and COHESion study group, COHESion study group},
  title = {Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort},
  journal = {Allergy},
  year = {2025},
  volume = {80},
  number = {4},
  pages = {1100--1110},
  doi = {10.1111/all.16463}
}
Kostenlos starten →